QualityStocksNewsBreaks Archives - Page 438 of 1422

FridayApr 29, 2022 10:56 am

QualityStocksNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) to Participate in Luxury Meets Cannabis Conference

Flora Growth’s (NASDAQ: FLGC) executives Luis Merchan and James Choe are scheduled to participate at the upcoming Luxury Meets Cannabis Conference. The two-day event is scheduled for May 5–6, 2022, in New York City. The premier B2B CBD, hemp and cannabis event — the first of its kind — is an ideal venue to shine a spotlight on FLGC’s impressive line of lifestyle products and brands. The conference is designed to bring together premium CBD, hemp and cannabis brands and their founders with representatives from top mainstream retailers, global media, leading dispensaries and investors. Flora Growth is a leading all-outdoor cannabis cultivator…

ThursdayApr 28, 2022 3:14 pm

QualityStocksNewsBreaks – Nowigence Inc. Streamlining How Teams Use Intelligence to Make Decisions, Complete Tasks

Nowigence provides a unique solution to the growing challenge of collaboration overload and the desperate need for tools that identify, organize and distribute information in a uniform way to provide access to critical information. The company accomplishes this through its Pluaris offering, which reads and analyzes articles, documents and other textual data, enabling users to learn more in less time, uncover hidden insights, and stay on top of the information they need to know. A recent article, which contains excerpts from Nowigence’s website, reads: “‘Communication is hard, and information is easily lost in translation, leading to duplication of effort in…

ThursdayApr 28, 2022 3:01 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Continues to Unlock Capabilities of Revolutionary DehydraTECH(TM) Platform

Lexaria Bioscience Corp. (NASDAQ: LEXX) is aware of the need to continuously improve its understanding of the capabilities and potential applications of its patented DehydraTECH(TM) drug delivery technology. This informs its long-held commitment to its applied research and development (“R&D”) programs. “So far, the company’s research journey has involved a series of controlled and well-designed in vitro preclinical testing and in vivo animal and human clinical studies…. Still, Lexaria is unrelenting in its pursuit of comprehensive datasets that would answer many questions the company expects to face from potential commercial partners or regulators and is, in fact, expanding its research.…

ThursdayApr 28, 2022 2:40 pm

QualityStocksNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Advancing Pipeline in Commitment to Transform Mental Health Treatment Landscape

Cybin (NYSE American: CYBN) (NEO: CYBN) is a leading ethical biopharmaceutical company working to advance psychedelic therapeutics for various psychiatric and neurological conditions in a commitment to transform the mental health treatment landscape. Through its proprietary deuterated process, Cybin is combining controllable drug-delivery systems with novel psychedelic molecules, thus creating patent-protected, commercially scalable drug candidates. “The company currently is moving three of these drug candidates forward: CYB003, CYB004 and CYB005. Cybin’s active drug programs target major depressive disorder (CYB003), alcohol use disorder (CYB003), anxiety disorders (CYB004) and neuroinflammation (CYB005),” reads a recent article. “Cybin recently announced that it commenced a…

ThursdayApr 28, 2022 1:43 pm

QualityStocksNewsBreaks – SPYR Inc. (SPYR) Evaluating Potential IP Acquisitions, Product Line Additions

SPYR (OTCQB: SPYR), dba SPYR Technologies, a technology company, and its subsidiary, Applied Magix Inc., is exploring potential acquisition opportunities that would expand the company’s essential intellectual property (“IP”) or product lines. Applied Magix develops and resells Apple(R) ecosystem-compatible products in the growing multibillion-dollar smart home and connected car markets, is investigating possible acquisition targets to add essential intellectual property to its line of products, as well as new product lines. According to Applied Magix CEO Dr. Harald Zink, Applied Magix is always on the lookout for new and innovative technologies and has recently identified several potential IP targets that are AI-based and…

ThursdayApr 28, 2022 1:34 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Secures Approval from Ethics Committee and Competent Authority in Spain for Potentially Pivotal Study

CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system (“CNS”). The company today announced its receipt of approval from the Spanish Agency for Medicines and Health Products (“AEMPS”) Competent Authority and from the CElm Provincial de Sevilla Ethics Committee in Spain for CNSP’s potentially pivotal study of Berubicin for the treatment of recurrent glioblastoma multiforme (“GBM”), one of the most aggressive types of brain cancer. “We continue to build momentum in our potentially pivotal study of Berubicin, and importantly advance toward bringing…

ThursdayApr 28, 2022 1:28 pm

QualityStocksNewsBreaks – GreenBox POS (NASDAQ: GBOX) to Participate in Taglich Brothers Conference

GreenBox (NASDAQ: GBOX), an emerging and rapidly growing fintech company, will be presenting during next month’s Taglich Brothers Investment Conference. The two-day event is scheduled for May 2–3, 2022, and will take place in New York City. GreenBox chair Ben Errez will be presenting during the event. His presentation will include a discussion of the company’s growing customized blockchain-based payment solutions along with an overview of the company’s strategic plans to become an integral presence in the digital payments landscape. Errez’s presentation is slated for May 2 at 4:15 p.m. ET. Taglich Brothers is a full-service brokerage firm specializing in…

ThursdayApr 28, 2022 1:06 pm

QualityStocksNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Signs Deal to Provide Three ASRs to San Francisco Bay Area Client

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies committed to enhancing U.S. security operations, continues to make major progress in its focus on market expansion. The company just announced that a San Francisco Bay Area biotech real estate development will be provided with two of its K5 ASRs and one K1 ASR to enhance the client’s amenity-rich real estate project and underscore the importance of public safety in a highly regulated environment. “Biotech firms, like any other type of business, need to be protected from break-ins, vandalism, and other intrusions,” the company stated in the press release. “Unlike…

ThursdayApr 28, 2022 12:47 pm

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Expands Patent Portfolio with Novel Cannabinoid Analogs, Initiates Strategic Research Collaboration Agreement

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today announced the publication of a patent application in North America. The application has broad claims directed to the molecular structure, uses and methods of manufacturing of several cannabinoid analogs. Describing several new cannabinoid-related chemical compounds, the broad patent application, if granted, allows for the creation of several variations of novel cannabinoid compounds, producing a robust library of proprietary new chemical entities (“NCEs”). “We believe rare cannabinoids hold tremendous therapeutic potential that may address a number of unmet medical needs,” said Eric Hsu, SVP,…

ThursdayApr 28, 2022 12:25 pm

QualityStocksNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Achieves Integration Milestone with First-Ever Sourcing of Its CBD into Market-Ready Products

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of cannabis products and brands, today announced that it has formally begun the integration of its licensed and Control Union Medical Cannabis Standard GACP (“CUMCS-GACP”) certified cannabis products and derivatives into its global roster of branded products. Beginning with CBD derivatives used in Mind Naturals, its award-winning skincare brand, the company has begun the process of integrating significantly lower-cost cannabinoids, grown and extracted at Flora’s cultivation and extraction facility, Cosechemos, for products formulated at the company’s GMP-licensed laboratory in Bogota, Colombia. The move marks a milestone in the company’s integration strategy,…

Site Search

Company Search

Category: QualityStocksNewsBreaks